We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
As a greater percentage of health care records are digitized, plus with the emergence of patient-provided data sets via wearables and other devices, therapy developers have much greater ability to distill insights from existing data rather than solely relying upon “started from scratch” clinical trials to learn about a disease. Companies are combining new analytical techniques with careful human screening of real world data sources such as electronic health records, insurance billing records, and patients’ mobile devices to develop real-world evidence regarding which patient populations might respond best to a new treatment under development and which diagnostic markers might streamline clinical trial recruitment. In the light of the FDA’s new guidance on real-world evidence this panel will explain how traditional approaches to clinical trial design may be enhanced to save time and money, while improving productivity and outcomes for patients.